Tumour necrosis factor-α: The role of this multifunctional cytokine in asthma

Immunology and Cell Biology

Volumn 79, Issue 2, 2001, Pages 132-140

  Thomas, P S ^a  

^a PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Airway inflammation; Airway reactivity; Asthma; Mast cells; Tumour necrosis factor

Indexed keywords

CYTOKINE; PROTEIN P55; PROTEIN P75; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

5' UNTRANSLATED REGION; AIRWAY RESISTANCE; ARTICLE; ASTHMA; GENETIC POLYMORPHISM; GENOTYPE; LUNG LAVAGE; MACROPHAGE; MAST CELL; MEDIATOR RELEASE; NEUTROPHILIA;

ANIMALS; ANTIGENS, CD; ASTHMA; CELL ADHESION MOLECULES; GENOTYPE; HUMANS; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035072754     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.2001.00980.x     Document Type: Article

References (112)

1. Human tumour necrosis factor: Precursor structure, expression and homology to lymphotoxin
2. Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or to calcium ionophores
3. Authentic 17kD tumor necrosis factor α is synthesised and released by canine mast cells and up-regulated by stem cell factor
4. Human eosinophils can express the cytokines tumor necrosis factor alpha and macrophage inflammatory protein-1 alpha
5. TNF alpha production by eosinophils in upper airways inflammation (nasal polyposis)
6. Effect of Haemophilus influenzae endotoxin on the synthesis of IL-6, IL-8, TNF alpha and expression of ICAM-1 in cultured human bronchial epithelial cells
7. Increased secretion of tumor necrosis factor α and interleukin-6 by alveolar macrophages consecutive to the development of the late asthmatic reaction
8. Heterogeneity of intact mast cell granules purified from canine mastocytoma cell lines
9. Tumor necrosis factor causes bronchial hyperresponsiveness in rats
10. Tumor necrosis factor alpha increases airway responsiveness and sputum neutrophilia in normal subjects
11. Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes
12. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor
13. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon
14. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma
15. Modulation of adhesion molecule expression on endothelial cells during the late asthmatic reaction: Role of macrophage-derived tumor necrosis factor-alpha
16. Differential regulation of eosinophil adhesion and transmigration by pulmonary microvascular endothelial cells
17. Role of interleukin-4 and vascular cell adhesion molecule-I in selective eosinophil migration into the airways in allergic asthma
18. Adhesion of activated eosinophils is enhanced by tumor necrosis factor alpha and interleukin-1 beta
19. Migration of primed human eosinophils across cytokine-activated endothelial cell monolayers
20. Eosinophil transendothelial migration induced by cytokines. II. Potentiation of eosinophil transendothelial migration by eosinophil-active cytokines
21. Activation of cAM-dependent pathways in human airway smooth muscle cells inhibits TNF alpha-induced ICAM-1 and VCAM-1 expression and T lymphocyte adhesion
22. Tumour necrosis factor alpha: A potential mediator of asthma
23. Induction of human airway responsiveness by tumour necrosis factor alpha
24. The effects of tumour necrosis factor alpha on mediator release from human lung
25. Activation of the TNF alpha-p55 receptor induces myocyte proliferation and modulates agonist-evoked calcium transients in cultured human tracheal smooth muscle cells
26. Mechanisms underlying TNF-alpha effects on agonist-mediated calcium homeostasis in human airway smooth muscle cells
27. Tumour necrosis factor alpha activates a calcium sensitization pathway in guinea-pig bronchial smooth muscle
28. Constitutive and cytokine-stimulated expression of eotaxin by human airway smooth muscle cells
29. The interaction of tumour necrosis factor alpha and endothelin-1 in pathogenetic models of asthma
30. Myofibroblasts and subepithelial fibrosis in bronchial asthma
31. Locally applied GM-CSF induces the accumulation of alpha-smooth muscle actin containing myofibroblasts
32. Tumor necrosis factor-induced expression of platelet-derived growth factor A-chain messenger RNA in fibroblasts
33. Mitogenic action of tumor necrosis factor in human fibroblasts: Interaction with epidermal growth factor and platelet-derived growth factor
34. Cell cultures from bronchial subepithelial myofibroblasts enhance eosinophil survival in vitro
35. Human eosinophils release matrix metalloproteinase -9 on stimulation with TNF alpha
36. Regulation of human lung fibroblast glycosoaminoglycan production by recombinant interferons, tumor necrosis factor, and lymphotoxin
37. Tumour necrosis factor alpha induces mucin hypersecretion and MUC-2 gene expression by human airway epithelial cells
38. Alveolar macrophages from atopic asthmatics, but not atopic nonasthmatics, enhance interleukin-5 production by CD4+ T cells
39. TNF-alpha-mediated lung cytokine networking and eosinophil recruitment in pulmonary fibrosis
40. Potential anti-inflammatory effects of interleukin 4: Suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2
41. Synergistic effects of interleukin-4 or interleukin-13 and tumour necrosis factor alpha on eosinophil activation in vitro
42. Human dermal mast cells contain and release tumor necrosis factor α, which induces endothelial leukocyte adhesion molecule 1
43. Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent
44. Stimulation of neutrophils by tumor necrosis factor
45. Neutrophil chemotactic activity in antigen-induced late asthmatic reactions
46. Migratory responses of eosinophil and neutrophil granulocytes from patients with asthma
47. Superoxide generation and its modulation by adenosine in the neutrophils of subjects with asthma
48. Products of neutrophils and eosinophils increase the responsiveness of human isolated bronchial tissue
49. Neutrophils and asthma
50. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation
51. Airway structure and inflammatory cells in fatal attacks of asthma
52. Lung-specific delivery of cytokines induces sustained pulmonary and systemic immunomodulation in rats
53. The intratracheal administration of endotoxin and cytokines
54. Inflammatory response to acute inhalation of endotoxin in asthmatic patients
55. Selective enhancement of GM-CSF, TNF alpha, IL-1 beta and IL-8 production by monocytes and macrophages of asthmatic subjects
56. Elevated release of tumor necrosis factor-alpha and interferon-gamma by bronchoalveolar leukocytes from patients with bronchial asthma
57. Tumor necrosis factor alpha and interleukin-6 production by human mononuclear phagocytes from allergic asthmatics after IgE-dependent stimulation
58. TNF alpha mRNA expression in allergic inflammation
59. Diisocyanate antigen-enhanced production of chemoattractant protein-1, IL-8, and tumour necrosis factor alpha by peripheral mononuclear cells of workers with occupational asthma
60. Changes in interleukin-1 and tumor necrosis factor production by peripheral blood monocytes after specific bronchoprovocation test in occupational asthma
61. Cytokines in the airway mucosa of subjects with asthma induced by toluene diisocyanate
62. Late response to allergen is associated with increased concentrations of tumor necrosis factor alpha and IL-5 in induced sputum
63. Tumor necrosis factor alpha and interleukin-1 beta. Two possible mediators of allergic inflammation
64. Elevation of serum soluble vascular cell adhesion molecule-1 (sVCAM-1) levels in bronchial asthma
65. Elevation of serum soluble intercellular adhesion molecule-1 (sICAM-1) and sE-selectin levels in bronchial asthma
66. Interleukin-4-5, and -6 and tumor necrosis factor alpha in normal and asthmatic airways: Evidence for the human mast cell as a source of these cytokines
67. Role of circulating inflammatory cytokines in patients during an acute attack of bronchial asthma
68. Serum levels of tumor necrosis factor alpha and soluble tumor necrosis factor receptor I in asthmatic patients with chronic respiratory infection
69. Segmental allergen challenge induces plasma protein leakage into the airways of asthmatic subjects at 4 hours but not at 5 minutes after challenge
70. Cytokine expression in normal, atopic, and asthmatic subjects using the combination of sputum induction and the polymerase chain reaction
71. Cytokine profiles of BAL T cells and T-cell clones obtained from human asthmatic airways after local allergen
72. Tumour necrosis factor is down-regulated in asthma and upregulated by inhaled corticosteroid: Comparative analysis by in situ hybridisation, immunocytochemistry and competitive RT-PCR in airway samples
73. Expression of inducible nitric oxide in human lung epithelial cells
74. Synergistic cytokine-induced nitric oxide production in human alveolar epithelial cells
75. Induction of nitric oxide synthase in asthma
76. Effect of a nitric oxide synthase inhibitor and a glucocorticoid on exhaled nitric oxide
77. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis
78. TNF receptors-how they function and interact
79. Transducing signals of life and death
80. Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: A role for TNF-R1 activation by endogenous membrane-anchored TNF
81. Autocrine regulation of matrix metalloproteinase-9 gene expression and secretion by tumor necrosis factor alpha (TNFα) in NB4 leukemic cells: Specific involvement of TNF receptor type 1
82. Expression of tumour necrosis factor receptors (CD120a and CD120b) on bronchoalveolar cells
83. Expression of three members of the TNF-R family of receptors (4-1BB, lymphotoxin-beta receptor, and Fas) in the human lung
84. Circadian rhythm of the soluble p75 tumor necrosis factor (sTNF-R75) receptor in humans - A possible explanation for the circadian kinetics of TNF-alpha effects
85. Tumour necrosis factor (TNF) gene polymorphism influences TNF alpha production in lipopolysaccharide (LPS) -stimulated whole blood cell culture in healthy humans
86. Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: Relevance to disease
87. Inherited variability of tumor necrosis factor production and susceptibility to infectious disease
88. Linkage and candidate gene studies in asthma
89. Tumour necrosis factor haplotypes and asthma
90. Extended tumour necrosis factor/HLA-DR haplotypes and asthma in an Australian population sample
91. Association of polymorphism within the tumour necrosis factor genes and childhood asthma
92. Association between -308 tumour necrosis factor promoter polymorphism and bronchial hyper-reactivity in asthma
93. Prevalence of tumor necrosis factor alpha and angiotensin converting enzyme polymorphisms in mild/moderate and fatal/near fatal asthma
94. Prevalence for tumour necrosis factor alpha -308 promoter polymorphism in atopic and asthmatic subjects
95. Effects of stimulus and cell type on the expression -308 tumour necrosis factor promoter polymorphism
96. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation
97. Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor alpha gene promoter
98. TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3
99. An essential role for ectodomain shedding in mammalian development
100. The importance of shedding of membrane proteins for cytokine biology
101. Processing of tumour necrosis factor α precursor by metalloproteinases
102. Glucocorticoids suppress tumor necrosis factor alpha expression by human monocytic THP-1 cells by suppressing transactivation through adjacent NF-kappa b and c-Jun-activating transcription factor-2 binding sites in the promoter
103. Taming TNF strategies to restrain this proinflammatory cytokine
104. Difference in the anti-inflammatory effects of theophylline: Important for the development of asthma therapy?
105. Thalidomide exerts its inhibitory action by enhancing mRNA degradation
106. Thalidomide reduces tumor necrosis factor alpha production by human alveolar macrophages
107. The effect of thalidomide and 2 analogs on collagen induced arthritis
108. Suppression of TNF and other proinflammatory cytokines by the tetravalent guanylhydrazone CNI-1493
109. Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing
110. A metalloproteinase inhibitor prevents lethal acute graft-versus-host disease in mice
111. Pharmacological evidence for tumor necrosis factor as a mediator of allergic inflammation in the airways
112. Prevention of Jarisch-Herxheimer reactions by treatment with antibodies against tumor necrosis factor alpha